Your session is about to expire
← Back to Search
Cannabis for Multiple Sclerosis (CANSEP Trial)
CANSEP Trial Summary
This trialwill assess the effects of cannabis on MS symptoms, such as spasticity, pain, and fatigue.
CANSEP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCANSEP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CANSEP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My kidney function is reduced with a creatinine clearance below 50 ml/min.My liver isn't working well, as shown by tests being three times above the normal limit.I am a man with fertility issues and plan to have children in the future.I can speak and read English or French at a ninth-grade level.I am 21 years old or older.I have a history of epilepsy or seizures.My MS-related muscle stiffness has been severe for over a month and current treatments aren't helping.I have not had schizophrenia or other major psychiatric disorders, except for anxiety or depression due to my condition.I haven't had serious heart problems in the last year.I do not have any health conditions that could risk my safety or affect the study's results.I've been on a stable dose of my current medication for at least 30 days.I have not had a botulinum toxin injection in the last 4 months and am willing to avoid them during the study.I have a condition that causes muscle stiffness or affects my muscle control.I have been diagnosed with MS for at least six months.I cannot or will not use birth control during the study.
- Group 1: CBD alone
- Group 2: THC alone
- Group 3: THC and CBD combined
- Group 4: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what extent is the participant pool for this trial growing?
"Absolutely. As outlined on clinicaltrials.gov, this medical research is presently recruiting candidates for the study which was initially announced on November 10th 2022 and recently updated on November 28th 2022. The aim of the trial is to enrol 250 participants from a single site."
Are there any vacancies for participation in this clinical trial?
"According to the info hosted on clinicaltrials.gov, this investigation is actively seeking out participants as it was initially published on November 10th 2022 with its most recent edition made available since November 28th of that same year."
Has the FDA granted single-compound CBD official endorsement?
"With a score of 2, our team at Power assesses the safety profile of CBD to be moderate. This is due to preliminary findings from Phase 2 trials that indicate some degree of safety but lack evidence for efficacy."
Share this study with friends
Copy Link
Messenger